Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia

NCT04522739 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Alzheimer Disease

Interventions

DRUG: Spironolactone
DRUG: Placebo

Sponsor

Emory University

Collaborators

[object Object]